Could the pharmacist in general practice model expand? A Symposium has examined how the model can work sustainably, with the RACGP saying it supports the move only if it can be made to work with funding.
What’s in the 2025–26 Federal Budget for GPs? The RACGP has welcomed GP workforce incentives but said while ‘it’s clear general practice is central in this year’s Budget’, there are still missed opportunities.
‘Not for sale’: Australia defends PBS against US big pharma GPs welcome plans to make PBS-listed medicines even cheaper, but it comes as US pharma giants take aim at the scheme.
‘The bane of my life’: Authority approvals under scrutiny A recent audit report has shed light on how one of the great admin burdens for general practice became even more onerous. What more can be done?
Prescriber reminder over oral contraceptive PBS changes Yaz and Yasmin are now available on the PBS – but existing patients will need a new prescription to access the lower price.
What to expect from incoming menopause health checks A new Medicare rebate is on the way, but what is a menopause health assessment and how will it improve the care women receive?
What does the $573m women’s health package mean for GPs? Labor’s plan, matched by the Coalition, includes new PBS listings for contraceptive pills and MHT, new rebates, funded training, and bolstered Medicare payments for IUD insertions.
‘Life-changing’ eczema drug to stay on PBS Dupixent was at high risk of coming off the PBS as soon as this month due to high demand, but negotiations have secured its continued listing.
Endometriosis drug Visanne added to PBS Doctors have described dienogest as ‘miraculous’, with its listing expected to positively impact up to 500,000 patients.
IV fluid supplies still a concern for rural GPs As wellness industry demand for IV fluids comes under increasing scrutiny, stocks remain a worry for GPs in more remote areas.